Načítá se...
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
OBJECTIVE: Recent evidence suggests the substantial pathogenic role of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in the development of low-grade chronic inflammatory response, known as “metaflammation,” which contributes to obesity and type 2 diabetes. In...
Uloženo v:
| Vydáno v: | Mol Metab |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267733/ https://ncbi.nlm.nih.gov/pubmed/32413585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|